Skip to main content

Walgreens, The Leukemia & Lymphoma Society and Susan G. Komen Collaborating to Support Research in Tough-to-Treat Cancers and Increase Access to Care

By LLS Staff | February 23, 2022

In February, Walgreens launched their annual spring fundraiser for The Leukemia & Lymphoma Society and Susan G. Komen to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, through 2024. Through a combination of online and in-store donations, the commitment enables research in metastatic breast and pediatric blood cancers, as well as increases access, treatment and support services for those living with these diseases. 

Available at checkout at the more than 9,000 U.S. Walgreens pharmacy locations in February, every donation will be split evenly between the two organizations. Funds raised thus far for LLS have helped accelerate the delivery of cancer treatment advances to pediatric patients and have helped caregivers and survivors handle the financial, emotional and psychological effects of cancer and its treatment. Further, funds have been used to design and launch specialized training courses for Walgreens pharmacists to offer more targeted care and resources for patients battling cancer, and to fund LLS’s Blood Cancer Conferences, which are free education events about treatment options, emerging therapies and managing survivorship.

“Our continued partnership with Walgreens is advancing the pediatric blood cancer research that we’re doing to deliver breakthroughs and ultimately lead to better and safer treatments for children with cancer,” said Louis DeGennaro, Ph.D., President and CEO of The Leukemia & Lymphoma Society. “It’s important to align with a partner who shares our commitment to accelerating cancer research and providing critical support and services to cancer patients, caregivers and their families.”

Find your local Walgreens store here.